TransMedics Group, Inc. TMDX

85.29 1.39 1.66% as of 25 Sep
Market cap
$2.9B
P/E
19.3×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
21.80 58.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
6.83 4.69 10.34 18.06 17.49 19.17 11.44 2.09 2.09 2.09
P/FCF ratio
30.96 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF
119.82 105.37 300.74 (418.33) (79.59) (68.87) (37.17) (4.36) (4.36) (4.36)
P/B ratio
8.74 9.06 18.20 9.01 7.80 4.73 4.94 0.00 0.00 0.00
Price to Tangible BV
9.00 9.64 20.33 9.01 7.80 4.73 4.94 0.00 0.00 0.00
EV/Sales
6.87 5.09 10.80 16.55 15.59 15.62 9.47 3.51 3.51 3.51
EV/EBITDA
30.64 39.24 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Operating CF
21.57 46.03 (200.39) (33.76) (16.35) (13.24) (6.92) (1.98) (1.98) (1.98)
EV/FCF
31.14 (27.76) (13.59) (26.80) (14.57) (13.04) (6.89) (1.95) (1.95) (1.95)
Quick Ratio
6.41 7.25 8.34 9.67 4.23 11.15 5.41 1.89 2.35 —
Current Ratio
7.14 8.30 9.30 10.66 5.11 12.36 6.21 2.77 3.12 —
Net Debt/EBITDA
0.18 3.02 (5.42) 5.04 1.52 3.67 1.64 (0.69) 0.81 0.00
Debt/Assets
47.96% 63.34% 71.70% 21.70% 26.09% 22.80% 32.43% 79.87% 0.00% —
Debt/Equity
1.08 2.23 3.69 0.32 0.52 0.33 0.62 (5.88) 0.49 —
Asset Turnover
0.65 0.58 0.49 0.45 0.21 0.20 0.32 0.62 0.19 0.00
Operating CF/Net income
1.01 1.38 0.52 1.26 0.65 1.05 0.96 1.09 1.11 1.01
Capex/Depreciation
(2.18) (6.57) (21.90) (3.42) (1.94) (0.29) (0.13) (0.54) 0.00 0.00
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
54.24% 19.39% (15.42%) (28.39%) (51.49%) (36.27%) 48.76% 13.16% 11.54% 0.00%
ROA
20.33% 4.70% (5.09%) (17.59%) (30.82%) (22.34%) (45.50%) (112.70%) (52.61%) 0.00%
ROIC
13.65% 5.84% (7.22%) (42.41%) (232.50%) (127.77%) (228.22%) (164.13%) 0.00% —
Return on Tangible Assets
21.72% 4.90% (3.97%) (14.62%) (41.99%) (20.59%) (37.83%) (92.38%) (81.35%) 0.00%
Average Days of Receivables
50.81 80.78 96.04 107.83 71.57 97.72 101.43 96.40 43.93 0.00
Research and Development Expense of Revenue
11.40% 12.68% 26.18% 28.69% 73.70% 73.45% 84.18% 104.91% 194.63% 251.84%
Selling, General and Administrative Expense of Revenue
30.58% 38.19% 49.48% 74.79% 126.51% 94.34% 99.97% 94.61% 95.98% 127.06%
Intangible Assets out of Total Assets
0.01 0.02 0.02 0.00 0.00 0.00 0.00 0.00 0.00 —
Share Based Compensation of Revenue
6.09% 7.52% 8.19% 11.04% 22.73% 9.42% 3.62% 1.11% 0.00% 0.00%
Graham Net Nets
0.01 (0.04) (0.02) 0.10 0.10 0.20 0.18 (0.67) (0.67) (0.67)
Graham Number
41.80 12.87 0.00 0.00 0.00 0.00 0.00 235.88 0.00 0.00
Earnings Yield
4.59% 1.72% (1.00%) (2.19%) (8.40%) (6.03%) (33.56%) (83.78%) (83.78%) (83.78%)
Free Cash Flow Yield
3.23% (3.91%) (7.69%) (3.42%) (6.12%) (6.25%) (12.02%) (86.10%) (86.10%) (86.10%)
Revenue per Share
17.81 13.29 7.43 3.16 1.10 1.04 1.66 9.58 0.39 0.31
Operating CF per Share
5.67 1.47 (0.40) (1.55) (1.05) (1.23) (2.27) (19.12) (1.16) (1.21)
Capex per Share
(1.74) (3.90) (5.51) (0.40) (0.13) (0.02) (0.01) (0.31) 0.00 0.00
Free Cash Flow per Share
3.93 (2.44) (5.91) (1.95) (1.17) (1.24) (2.28) (19.43) (1.16) (1.21)
Cash per Share
14.37 10.13 12.14 6.81 3.35 5.09 5.68 14.89 1.24 0.00
Shareholders Equity per Share
13.92 6.88 4.22 6.34 2.46 4.21 3.85 (4.21) 0.89 0.00
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
13.92 6.88 4.22 6.34 2.46 4.21 3.85 (4.21) 0.89 0.00
Free Cash Flow
133.59 (80.94) (192.09) (57.72) (32.38) (30.72) (32.45) (26.40) (23.10) (24.19)
Working Capital
548.48 437.30 455.72 228.63 95.47 134.89 83.89 22.24 23.14 —
Capital Expenditures
(59.25) (129.74) (179.06) (11.91) (3.52) (0.45) (0.16) (0.42) (0.26) (1.48)
Net Current Asset Value
42.51 (78.26) (58.19) 162.52 51.67 98.63 49.35 (13.09) 14.83 —
EV/EBIT
38.31 59.91 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales
0.10 0.29 0.74 0.13 0.12 0.02 0.01 0.03 0.00 0.00
Net Profit Margin
31.43% 8.03% (10.36%) (38.77%) (146.11%) (112.13%) (142.12%) (182.50%) (270.96%) (387.58%)
Price to Operating Income
38.08 55.26 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.08 0.07 0.05 0.18 0.18 0.33 0.26 0.22 0.26 0.00
Cash ROIC
(9.15%) (22.07%) (18.01%) (14.50%) (19.80%) (13.26%) (21.88%) (61.13%) (50.00%) 0.00%
Accounts Receivable Turnover
6.65 5.47 5.30 5.57 4.73 3.82 4.72 5.97 3.52 0.00
Accounts Payable Turnover
23.51 15.60 10.90 5.64 2.32 2.13 1.63 1.77 2.52 2.48
Inventory Turnover
5.09 3.95 2.70 1.59 0.68 0.78 0.95 0.84 1.81 1.78
Average Days of Payables
15.57 20.93 53.03 43.26 266.68 48.89 271.55 236.55 222.04 68.38
Days of Inventory on Hand
73.52 94.69 184.46 266.82 595.80 483.78 420.27 464.93 503.53 (102.18)
Average Receivables
91.00 80.65 45.59 16.77 6.40 6.71 5.00 2.18 2.18 —
Average Payables
10.32 11.50 8.03 5.00 3.93 4.23 5.98 4.12 2.29 2.29
Average Inventory
47.72 45.39 32.42 17.73 13.40 11.58 10.25 8.62 3.19 3.19
Average Assets
936.22 755.06 491.60 206.02 143.46 128.66 73.73 21.08 39.58 —
Average Common Equity
350.85 182.90 162.29 127.61 85.87 79.27 (68.80) (180.48) (180.48) —

Fold the line items

Columns are period end dates